Ovarian Hyperstimulation Syndrome
📧 Sign up to get email alerts when something new happens for Ovarian Hyperstimulation Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Endometrial Receptivity After GnRH Agonist Triggering [Phase 4]
A Phase 4 clinical trial evaluating endometrial receptivity after GnRH agonist triggering has completed. The sponsor is IVI Madrid.
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome [Phase 2]
Phase 2 trial update assessing the efficacy and safety of dexamethasone to prevent ovarian hyperstimulation syndrome in patients.
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome [Phase 2]
Phase 2 trial evaluating a Gonadotropin Releasing Hormone Antagonist for early-onset severe ovarian hyperstimulation syndrome has completed.…
-
CLINICAL_TRIALS withdrawal · 2016-05-26Clinical Trial Update: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes [NA]
The Antalya IVF-sponsored trial evaluating a dual trigger strategy for intracytoplasmic sperm injection reproductive outcomes has been withd…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) [Phase 3]
A Phase 3 trial evaluating degarelix in controlled ovarian hyperstimulation for women with polycystic ovary syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-03-30Clinical Trial Update: Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) [Phase 1, Phase 2]
A Phase 1/2 study evaluating an increased dose GnRH antagonist for coasting to lower ovarian hyperstimulation syndrome risk has been withdra…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]
Phase 2/3 trial comparing diosmin with cabergoline for prevention of ovarian hyperstimulation syndrome in infertility completed.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS [Phase 4]
Phase 4 trial suggests that preventive use of letrozole reduces the incidence of early-onset ovarian hyperstimulation syndrome.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Short Versus Long Protocol for IVF and IVF+ICSI [Phase 4]
A Phase 4 trial comparing short versus long IVF protocols (with IVF and IVF+ICSI) has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome [Phase 2]
This is a Phase 2 clinical trial update evaluating cabergoline versus a GnRH antagonist rescue and cabergoline for the prevention of ovarian…
-
CLINICAL_TRIALS withdrawal · 2015-09-04Clinical Trial Update: Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation. [NA]
A clinical trial comparing fresh versus frozen embryo transfer in IVF cycles using a GnRH agonist for oocyte maturation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? [Phase 4]
Phase 4 clinical trial evaluating whether a GnRH agonist trigger can prevent ovarian hyperstimulation syndrome has been terminated. The stud…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program [Phase 1, Phase 2]
Phase 1/2 clinical trial comparing human albumin with cabergoline to prevent ovarian hyperstimulation syndrome in assisted reproductive tech…
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders
A clinical trial update examining monitoring the early follicular phase with androstenedione in a low-dose step-up ovulation induction strat…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) [NA]
This is an update on a trial comparing a luteal antagonist to conventional treatment for severe early ovarian hyperstimulation syndrome (OHS…
-
CLINICAL_TRIALS research · 2015-02-09Clinical Trial Update: Prediction of High Ovarian Response After Assisted Reproductive Techniques
This entry reports an update on a clinical trial that aims to predict high ovarian response after assisted reproductive techniques, with foc…
-
CLINICAL_TRIALS research · 2014-07-29Clinical Trial Update: Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients
This clinical trial update notes a study evaluating serum oxidative stress markers in patients with ovarian hyperstimulation syndrome, but p…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Calcium for Prevention of Ovarian Hyperstimulation Syndrome [Phase 3]
Phase 3 trial evaluating calcium for prevention of ovarian hyperstimulation syndrome has completed; results are not provided in the snippet.
-
CLINICAL_TRIALS research · 2014-03-12Clinical Trial Update: Long Acting GnRH Antagonist in PCOS Women Undergoing IVF
A clinical trial update describes a long-acting GnRH antagonist studied in women with polycystic ovary syndrome undergoing IVF. The trial st…
-
CLINICAL_TRIALS research · 2013-12-27Clinical Trial Update: Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome [NA]
This clinical trial update describes a dual trigger approach aimed at reducing ovarian hyperstimulation syndrome in infertility patients at …
-
CLINICAL_TRIALS trial_result · 2013-12-27Clinical Trial Update: Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome [NA]
An update on a clinical trial evaluating repeated injections of a GnRH agonist to reduce ovarian hyperstimulation syndrome in women with inf…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles [Phase 4]
Phase 4 study assessing triggering final oocyte maturation with the GnRH agonist buserelin in GnRH antagonist cycles; results related to ova…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome [Phase 3]
A Phase 3 trial evaluating a GnRH antagonist for the treatment of early ovarian hyperstimulation syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors [NA]
A completed clinical trial evaluated the use of Cetrotide acetate (cetrorelix acetate) to prevent ovarian hyperstimulation syndrome in oocyt…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist
Trial evaluating GnRH agonist–based prevention of ovarian hyperstimulation syndrome has completed.